Perrigo Ends 2017 As It Started: Earnings Results Delayed

The OTC drug, nutritional products and Rx generics manufacturer reported interim and unaudited results for 2017 and said it will release its entire earnings statement on a date yet to be determined because "it needs additional time to complete its final income tax review procedures related to reconciliations of specific non-cash items.2018 begins with new CEO Uwe Rohrhoff at the helm.

Business time concept as a group of running businessmen and businesswomen using a giant clock to cross over a cliff as a bridge as a metaphor for schedule and appointment speed as a 3D illustration.

Perrigo Co. PLC ended 2017 as it began the year, with its latest quarterly earnings results delayed. It put its fourth-quarter results on hold to figure out its taxes while its first-quarter results were delayed to restate some revenues.

The OTC drug, adult and infant nutritional products and Rx specialty topical generics manufacturer on Feb. 27 reported interim and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography